Recommended: Click here to improve PC speed »
The system itself is a capacity simulator , a sophisticated modelling tool whichuses statistical methods to predict how chemotherapy units will perform underdifferent conditions. It allows chemotherapy units to plan for the uptake of newcancer medicines and redesign the way they deliver chemotherapy to improveefficiency and patient experience.
Over 80 front line staff were consulted during the design and test programme and itis currently being rolled out across the NHS with overwhelming support from thedoctors, nurses, pharmacists and managers who will use it. Professor Mike Richards,the National Cancer Director said: I strongly recommend that Cancer Networks andtheir stakeholders use this tool to improve forward planning for cancer drugs.
The tool was designed for the POIP by A.T. Kearney, a management consultancy, andbuilt by Concentra, a UK IT provider, and ITransition, an offshore developer. SaidJonathan Anscombe, head of the A.T. Kearney health practice: It proved to be areally complicated problem, so C-PORT pushes the boundaries of this type ofsimulation tool.
The success of the project also shows how the pharmaceutical industry cancollaborate effectively with the NHS for the benefit of patients. Suchcollaborations have an important role to play in helping to improve healthdelivery, said Dr Richard Barker, Director General of the ABPI.
For more information please contact:
CIO Magazine is one of the leading magazines for IT professionals. Every year, theCIO 100 Awards honour 100 companies that demonstrate excellence and achievement inIT. The process for choosing the CIO 100 honorees is systematic and verycompetitive. The prize is for companies that are using IT in innovative ways todeliver competitive advantage to the enterprise and enable growth. www.cio.com
Pharmaceutical Oncology Initiative Partnership (POIP) was set up in 2005 to identifyopportunities to collaborate on projects to benefit cancer patients by improvinguptake and access to cancer medicines. The partners include the Cancer Action Team,NHS Cancer Services Collaborative Improvement Partnership and the PharmaceuticalOncology Initiative (POI), a group of pharmaceutical companies who research, developand supply innovative cancer medicines. The 12 companies which have supported C-PORTare all members of the Association of the British Pharmaceutical Industry (ABPI);Amgen, AstraZeneca , Lilly, Merck Serono, GlaxoSmithKline, Novartis, Ortho Biotech,Pfizer, Roche, Sanofi-Aventis, Schering-Plough and Wyeth. Contactjh&a@holdingassociates .co.uk
A.T. Kearney is a global management consultancy providing strategy and operationsconsulting to leading companies in many industries, including healthcare. ContactJonathan.anscombe@atke arney.com
Concentra is a Microsoft Gold Partner with a proven track record in developing,implementing and supporting technology solutions to help clients get the most fromtheir IT investment. www.concentra.co.uk
Itransiti on is an international software development company featured in GlobalOutsourcing 100 edition with development centers in Eastern Europe. With the pool ofmore than 450 software developers in staff Itransition specializes in enterpriselevel application development for medium size and big business. www.itransition.com
